Item 4. Controls and Procedures
ITEM
4.
CONTROLS
AND PROCEDURES
We
maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports pursuant
to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities
and Exchange Commission, and that such information is accumulated and communicated to our management, including our Executive Chairman
of the Company, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls
and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable
assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its
judgment in evaluating the cost-benefit relationship of possible controls and procedures.
In
connection with the preparation of this Quarterly Report on the Form 10-Q, we carried out an evaluation, under the supervision and with
the participation of our management including our Executive Chairman of the Company, of the effectiveness of the design and operation
of our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of September 30, 2023.
Based upon that evaluation and other than as disclosed herein, our Chief Executive Officer and Chief Financial Officer concluded that
our disclosure controls and procedures were effective as of the end of the period covered by this report.
During
our preparation of our Annual Report on Form 10-K for the year ended December 31, 2023, we identified a material weakness with financial
reporting whereby the Company did not have properly designed internal controls over timely preparation and independent review of account
analyses, account summaries and account reconciliations. These internal control failures resulted in material adjustments required to
properly state expense, inventory, deferred revenue, accrued expenses, accounts receivables, and revenues as of and for the year ending
December 31, 2022. This material weakness could result in the Company incorrectly reporting its condensed consolidated balance sheets,
condensed consolidated statement of operations, condensed stockholder’s equity, and condensed consolidated statements of cash flows.
To remediate the material weakness, the Company is instituting reporting enhancements within its accounting system, standardized and
timely account reconciliations, and independent and regular reviews by the finance department to ensure the Company records are complete
and accurate. In addition, the Company will hire an additional resource to provide additional oversight in the reviews and completion
of timely analysis and reconciliations. The material weakness will not be considered remediated until the applicable remedial controls
operate for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively.
We expect that the remediation of this material weakness will be completed before the end of 2023.
Other
than as disclosed herein, there were no changes in our internal control over financial reporting during the three months ended September
30, 2023 that have affected, or are reasonably likely to affect, our internal control over financial reporting.
26
PART
II - OTHER INFORMATION
ITEM
1.
LEGAL
PROCEEDINGS
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.